Saeeda Paruk1, Khatija Jhazbhay1, Keshika Singh1, Benn Sartorius2, Jonathan K Burns1. 1. Department of Psychiatry, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa. 2. Department of Public Health, Nelson R Mandela School of Medicine, University of KwaZulu-Natal, Durban, South Africa.
Abstract
BACKGROUND: Comorbid substance use, particularly cannabis among adolescents with mental illness, is a major public health concern in developing countries with limited mental health resources. Better understanding of the association between cannabis use and other polysubstance use and early mental illness will provide for more targeted early interventions. AIM: This aim of this study was to examine the socio-demographic profile and cannabis use characteristics among adolescents with first-episode early-onset psychosis (EOP) and compare with age-matched and gender-matched adolescents with first-episode non-psychotic mental illness (controls). METHOD: Forty-five adolescents with first-episode EOP and 45 controls were assessed using a clinical interview, Positive and Negative Syndrome Scale and World Health Organization Alcohol, Smoking and Substance Involvement Screening test (ASSIST) for substance-related problems. RESULTS: There were significant socio-demographic differences among the adolescents with EOP (73% Black, 64% from low family income, 44% from rural areas) compared with controls (24% Black, 53% from low family income, 2% from rural areas). Although there was no difference in lifetime cannabis use, EOP adolescents differed in motivation for cannabis use, had increased current cannabis use (38%, P = 0.01) and more frequent use (52%, P = 0.04) compared with controls (16% current and 18% frequent use). EOP adolescents reported more hazardous use with higher ASSIST mean cannabis-specific involvement scores (EOP 10,2; controls 2,3; P = 0.004). CONCLUSION: The differences in socio-demographic variables may reflect the marked disparity in access to mental health care for rural Black youth. Psychotic youth may be more vulnerable to comorbid cannabis-related problems than other mentally ill adolescents. The study highlights the need for early introduction of substance use interventions among adolescents with mental illness.
BACKGROUND: Comorbid substance use, particularly cannabis among adolescents with mental illness, is a major public health concern in developing countries with limited mental health resources. Better understanding of the association between cannabis use and other polysubstance use and early mental illness will provide for more targeted early interventions. AIM: This aim of this study was to examine the socio-demographic profile and cannabis use characteristics among adolescents with first-episode early-onset psychosis (EOP) and compare with age-matched and gender-matched adolescents with first-episode non-psychotic mental illness (controls). METHOD: Forty-five adolescents with first-episode EOP and 45 controls were assessed using a clinical interview, Positive and Negative Syndrome Scale and World Health Organization Alcohol, Smoking and Substance Involvement Screening test (ASSIST) for substance-related problems. RESULTS: There were significant socio-demographic differences among the adolescents with EOP (73% Black, 64% from low family income, 44% from rural areas) compared with controls (24% Black, 53% from low family income, 2% from rural areas). Although there was no difference in lifetime cannabis use, EOP adolescents differed in motivation for cannabis use, had increased current cannabis use (38%, P = 0.01) and more frequent use (52%, P = 0.04) compared with controls (16% current and 18% frequent use). EOP adolescents reported more hazardous use with higher ASSIST mean cannabis-specific involvement scores (EOP 10,2; controls 2,3; P = 0.004). CONCLUSION: The differences in socio-demographic variables may reflect the marked disparity in access to mental health care for rural Black youth. Psychotic youth may be more vulnerable to comorbid cannabis-related problems than other mentally ill adolescents. The study highlights the need for early introduction of substance use interventions among adolescents with mental illness.
Authors: M Lambert; P Conus; D I Lubman; D Wade; H Yuen; S Moritz; D Naber; P D McGorry; B G Schimmelmann Journal: Acta Psychiatr Scand Date: 2005-08 Impact factor: 6.392
Authors: G Estrada; M Fatjó-Vilas; M J Muñoz; G Pulido; M J Miñano; E Toledo; J M Illa; M Martín; M L Miralles; S Miret; S Campanera; C Bernabeu; M E Navarro; L Fañanás Journal: Acta Psychiatr Scand Date: 2011-01-14 Impact factor: 6.392
Authors: Josefina Castro-Fornieles; Mara Parellada; Ana Gonzalez-Pinto; Dolores Moreno; Montserrat Graell; Immaculada Baeza; Soraya Otero; Cesar A Soutullo; Benedicto Crespo-Facorro; Ana Ruiz-Sancho; Manuel Desco; Olga Rojas-Corrales; Ana Patiño; Eugenio Carrasco-Marin; Celso Arango Journal: Schizophr Res Date: 2007-01-30 Impact factor: 4.939
Authors: Anna Kolliakou; Candice Joseph; Khalida Ismail; Zerrin Atakan; Robin M Murray Journal: Int J Dev Neurosci Date: 2010-12-21 Impact factor: 2.457
Authors: Jennifer H Barnett; Ursula Werners; Sandra M Secher; Katherine E Hill; Rossa Brazil; Kim Masson; David E Pernet; James B Kirkbride; Graham K Murray; Ed T Bullmore; Peter B Jones Journal: Br J Psychiatry Date: 2007-06 Impact factor: 9.319
Authors: Suzanne Archie; Lena Palaniyappan; Andrew T Olagunju; Natasha Johnson; Nicole Kozloff; Elham Sadeh; Andrea Bardell; Alexandra Baines; Kelly K Anderson; Oyedeji Ayonrinde; Manuela Ferrari Journal: JMIR Res Protoc Date: 2022-05-20
Authors: Emmanuel K Mwesiga; Andrew S Ssemata; Joy Gumikiriza; Angel Nanteza; Anne Jacqueline Nakitende; Juliet Nakku; Dickens Akena; Noeline Nakasujja Journal: Health Qual Life Outcomes Date: 2022-07-23 Impact factor: 3.077